About the Company
PetVivo Holdings, Inc. is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The Company's strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics. PetVivo has a pipeline of seventeen products for the treatment of animals and people. A portfolio of twenty-one patents protects the Company's biomaterials, products, production processes and methods of use. The Company’s lead product Kush, a veterinarian-administered, intraarticular injection for the treatment of osteoarthritis in dogs and horses, is scheduled for expanded commercial sale later this year.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PETV News
PetVivo Holdings, Inc. (PETV) Q2 2023 Earnings Call Transcript
All right. Let us begin the conference. Greetings and welcome to the PetVivo Holdings Second Quarter Fiscal Year 2023 Financial Results Conference Call. I am John Dolan, the Chief Business ...
PETVIVO HOLDINGS, INC. TO PRESENT AT LD MICRO MAIN EVENT XV
MINNEAPOLIS, Oct. 18, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo"), an emerging biomedical device company focused on the commercialization of innovative ...
PETV PetVivo Holdings, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. Is this happening to you frequently? Please report it on our ...
PetVivo Holdings, Inc. to Exhibit at American Association of Equine Practitioners Conference in San Antonio, Texas
MINNEAPOLIS, MN, US, Nov. 09, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV, PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of ...
PetVivo Reports Second Quarter of Fiscal 2023 Financial Results
EDINA, MN, Nov. 10, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. ("PetVivo" or the "Company") PETV, an emerging biomedical device company focused on the commercialization of innovative medical ...
PetVivo Holdings, Inc. to Exhibit at American Association of Equine Practitioners Conference in San Antonio, Texas
Get 7 Days Free Sign In Sign In Topics ...
PetVivo Reports Second Quarter of Fiscal 2023 Financial Results
EDINA, MN, Nov. 10, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (“PetVivo” or the “Company”) (Nasdaq: PETV), an emerging biomedical device company focused on the commercialization of ...
Loading the latest forecasts...